Evidence method
Level · gp.fundamentals.debt_to_revenue
48.60% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
WST · Jun 30, 2020
WEST PHARMACEUTICAL SERVICES INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000105770-20-000045General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
7.04% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
28.09% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
12.24% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
52.12% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
37.01% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
19.65% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.05% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
2.31% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History39 statesSelf-history eligible
Mar 31, 201910/10 normalizedLevel 3Jun 30, 201910/10 normalizedLevel 3Sep 30, 201910/10 normalizedLevel 3Dec 31, 20198/8 normalizedLevel 3Mar 31, 20209/9 normalizedLevel 3Jun 30, 20209/9 normalizedLevel 3Sep 30, 20209/9 normalizedLevel 3Dec 31, 20209/9 normalizedLevel 3Mar 31, 20219/9 normalizedLevel 3Jun 30, 20219/9 normalizedLevel 3Sep 30, 20219/9 normalizedLevel 3Dec 31, 20219/9 normalizedLevel 3Mar 31, 20229/9 normalizedLevel 3Jun 30, 20229/9 normalizedLevel 3Sep 30, 20229/9 normalizedLevel 3Dec 31, 20229/9 normalizedLevel 3Mar 31, 20239/9 normalizedLevel 3Jun 30, 20239/9 normalizedLevel 3Sep 30, 20239/9 normalizedLevel 3Sep 30, 20269/9 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 52.23%
- Current
- 48.60%
- Delta
- -3.63%
- Previous
- 6.53%
- Current
- 7.04%
- Delta
- 0.51%
- Previous
- 11.62%
- Current
- 28.09%
- Delta
- 16.47%
- Previous
- 10.82%
- Current
- 12.24%
- Delta
- 1.42%
- Previous
- 51.07%
- Current
- 52.12%
- Delta
- 1.06%
- Previous
- 33.98%
- Current
- 37.01%
- Delta
- 3.03%
- Previous
- 17.90%
- Current
- 19.65%
- Delta
- 1.75%
- Previous
- 2.18%
- Current
- 2.05%
- Delta
- -0.13%
- Previous
- 1.10%
- Current
- 2.31%
- Delta
- 1.22%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · WST Fundamental State →Has State · WEST PHARMACEUTICAL SERVICES INC →Transitioned To · WST Fundamental State →Transitioned To · WST BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · WST CAPEX_INTENSITY_INCREASED →Transitioned To · WST CASH_GENERATION_INCREASED →Transitioned To · WST GROWTH_INCREASED →Transitioned To · WST INVENTORY_PRESSURE_INCREASED →Transitioned To · WST MARGIN_INCREASED →Transitioned To · WST PROFITABILITY_INCREASED →Transitioned To · WST R_AND_D_INTENSITY_DECREASED →Transitioned To · WST SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.